From: 3D-CT implanted interstitial brachytherapy for T2b nasopharyngeal carcinoma
Patient Characteristics | ERT/3D-HDR-BT n (%) | ERT n (%) | P-value |
---|---|---|---|
Age (years) | Â | Â | 0.743 |
   ≤ 45 | 23 (57.5%) | 55 (54.5%) |  |
   > 45 | 17 (42.5%) | 46 (45.5%) |  |
Gender | Â | Â | 0.252 |
   Male | 34 (85.0%) | 77 (76.2%) |  |
   Female | 6 (15.0%) | 24 (23.8%) |  |
Histology | Â | Â | 0.956 |
   WHO type I | 1 (2.5%) | 3 (3.00%) |  |
   WHO type II/III | 39 (97.5%) | 98 (97.0%) |  |
UICC stage | Â | Â | 0.064 |
   II | 32 (80.0%) | 89 (88.1%) |  |
   III | 6 (15.0%) | 12 (11.9%) |  |
   IV a | 2 (5.0%) | 0 (0%) |  |
N stage | Â | Â | 0.282 |
   N0-1 | 21 (52.5%) | 58 (57.4%) |  |
   N2 | 17 (42.5%) | 43 (42.6%) |  |
   N3 | 2 (5.0%) | 0 |  |
Therapy | Â | Â | 0.264 |
   Received | 19 (78.4%) | 43 (81.4%) |  |
   Not received | 21 (14.9%) | 58 (1.5%) |  |